Enlivex Sets October 14 Vote on 1-for-16 Reverse Split to Regain Nasdaq Compliance
ENLV is trading near its 52-week low of $0.47 (5.4% above the low).
Summary
Enlivex will hold an extraordinary shareholder meeting on October 14 to vote on a 1-for-16 reverse split aimed at regaining Nasdaq's $1.00 minimum bid compliance. The stock has traded below $1.00 since September 10, and a delisting determination could come as soon as October 21.
Updates
· SEC 6-K/A — The meeting is moved to October 16, 2026, and the proposal now seeks approval for a reverse split range of 1-for-13 to 1-for-16 plus authorization for additional splits up to 1-for-1,000 within 12 months.
Key Events · Corporate Governance and Compliance · ENLV
-
1-for-16 Reverse Split Proposed
Shareholders will vote October 14 on a 1-for-16 reverse split, effective as soon as possible after approval, to lift the share price above Nasdaq's $1.00 minimum.
-
Nasdaq Delisting Deadline Looms
The stock has closed below $1.00 every trading day since September 10, 2026. If it remains below $1.00 through October 21, Nasdaq will issue a delisting determination with no 180-day compliance period.
-
Second Reverse Split in Three Months
This follows a 1-for-15 reverse split effective July 9, 2026, indicating the prior adjustment did not sustain the required price level.
-
Meeting and Record Dates Set
Record date is October 5, 2026; the extraordinary general meeting is October 14, 2026 at 10:00 a.m. Israel time in Ness Ziona.
Analysis · ENLV · Life Sciences
Enlivex is asking shareholders to approve a 1-for-16 reverse split after its stock closed below the $1.00 Nasdaq minimum every day since September 10. If the price stays under $1.00 through October 21, Nasdaq will issue a delisting determination with no 180-day grace period. The board is moving quickly — the meeting is set for October 14, just seven days before that deadline. This is the second reverse split in three months, following the 1-for-15 split in July, which signals the company is struggling to hold its share price above the threshold despite the prior adjustment.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.5% of the 1055 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ENLV was trading at $0.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.4M. The 52-week trading range was $0.47 to $27.15. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.